기관지폐형성이상의 혈관적 측면

키워드

참고문헌 (31)

1. Northway WH Jr, "Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia", N Engl J Med, 276, pp.357~368 (1967)
2. Jobe AH, "Bronchopulmonary dysplasia", Am J Respir Crit Care Med, 163, pp.1723~1729 (2001)
3. Coalson JJ, "Pathology of bronchopulmonary dysplasia", Semin Perinatol, 30, pp.179~184 (2006)
4. Walter EC, "Low birth weight and respiratory disease in adulthood: a populationbased case-control study", Am J Respir Crit Care Med, 180, pp.176~180 (2009)
5. Doyle LW, "Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence", Pediatrics, 118, pp.108~113 (2006)
6. Doyle LW, "Adult outcome of extremely preterm infants", Pediatrics, 126, pp.342~351 (2010)
7. Speer CP, "Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia", Neonatology, 95, pp.353~361 (2009)
8. Choi CW, "Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: Morphometric aspects", Pediatric Research, 65(3), pp.323~327, Lippincott Williams & Wilkins Ltd.
9. Stenmark KR, "Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia", Annu Rev Physiol, 67, pp.623~661 (2005)
10. Parera MC, "Distal angiogenesis: a new concept for lung vascular morphogenesis", Am J Physiol Lung Cell Mol Physiol, 288, pp.L141~L149 (2005)
11. Filipovic N, "Computational flow dynamics in a geometric model of intussusceptive angiogenesis", Microvasc Res, 78, pp.286~293 (2009)
12. Galambos C, "Molecular mechanisms of pulmonary vascular development", Pediatr Dev Pathol, 10, pp.1~17 (2007)
13. Bhatt AJ, "Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia", Am J Respir Crit Care Med, 164, pp.1971~1980 (2001)
14. Quintos-Alagheband ML, "Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia", Antioxid Redox Signal, 6, pp.137~145 (2004)
15. Schwarz M, "EMAP II: a modulator of neovascularization in the developing lung", Am J Physiol, 276, pp.L365~L375 (1999)
16. Yamashita J, "Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors", Nature, 408, pp.92~96 (2000)
17. Voelkel NF, "Vascular endothelial growth factor in the lung", Am J Physiol Lung Cell Mol Physiol, 290, pp.L209~L221 (2006)
18. Acarregui MJ, "Vascular endothelial growth factor gene expression in human fetal lung in vitro", Am J Respir Cell Mol Biol, 20, pp.14~23 (1999)
19. Thebaud B, "Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization", Circulation, 112, pp.2477~2486 (2005)
20. Lassus P, "Vascular endothelial growth factor in human preterm lung", Am J Respir Crit Care Med, 159, pp.1429~1433 (1999)
21. 조수진, "Retinoic acid and erythropoietin maintain alveolar development in mice treated with all angiogenesis inhibitor", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 33(6), pp.622~628, AMER THORACIC SOC
22. Jakkula M, "Inhibition of angiogenesis decreases alveolarization in the developing rat lung", Am J Physiol Lung Cell Mol Physiol, 279, pp.L600~L607 (2000)
23. Le Cras TD, "Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure", Am J Physiol Lung Cell Mol Physiol, 283, pp.L555~L562 (2002)
24. Lassus P, "Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn", Am J Respir Crit Care Med, 164, pp.1981~1987 (2001)
25. Compernolle V, "Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice", Nat Med, 8, pp.702~710 (2002)
26. Zeng X, "VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo", Dev Dyn, 211, pp.215~227 (1998)
27. Kroll J, "A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells", Biochem Biophys Res Commun, 265, pp.636~639 (1999)
28. Lin YJ, "Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats", Pediatr Res, 58, pp.22~29 (2005)
29. Donohue PK, "Inhaled nitric oxide in preterm infants: a systematic review", Pediatrics, 127, pp.e414~e422 (2011)
30. Mercier JC, "Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial", Lancet, 376, pp.346~354 (2010)
31. Asikainen TM, "Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo", Am J Physiol Lung Cell Mol Physiol, 291, pp.L588~L595 (2006)

관련 논문AI추천